Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy [EPC]

2 reported adverse events

Drugs of this class: HUMAN CORD BLOOD HEMATOPOIETIC PROGENITOR CELL

These side effects are most commonly reported by patients taking drugs of the Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy [EPC] class:

# Side effect Count
0 COMMUNICATION DISORDER 2
1 INSOMNIA 2
2 ANXIETY 1
3 ARTHRALGIA 1
4 BACK PAIN 1
5 BURNING SENSATION 1
6 CHILLS 1
7 CONSTIPATION 1
8 DECREASED APPETITE 1
9 DEPRESSION 1
See all common reactions for Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy [EPC]

Drugs of the Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COMMUNICATION DISORDER 2 0.0006
1 GASTROINTESTINAL ULCER 1 0.0005
2 DEPRESSIVE SYMPTOM 1 0.0004
3 TRIGEMINAL NEURALGIA 1 0.0003
4 HEPATIC PAIN 1 0.0003
5 ULCER HAEMORRHAGE 1 0.0002
6 SPINAL OSTEOARTHRITIS 1 0.0001
7 SPINAL PAIN 1 0.0001
8 PHARYNGITIS 1 0.0001
9 PRODUCT AVAILABILITY ISSUE 1 0.0001
See all enriched reactions for Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy [EPC]